Sherilyn McCoy

Sherilyn D.
McCoy is Non-Executive Chairman at Aldevron LLC and Chairman at Certara Holdings, Inc. She is Chairman at PAREXEL International Corp.
since 2021 and Chairman at Dechra Pharmaceuticals Ltd. since 2024.
She serves as Vice Chairman at Galderma Group AG since 2022.
She is Lead Independent Director at Kimberly-Clark Corp.
since 2024 and at Stryker Corp.
since 2022.
She is Independent Non-Executive Director at AstraZeneca PLC since 2017.
She holds director positions at Catalyst, Inc., Galderma Laboratories LP, Galderma Holding SA, and Sail Biomedicines Inc. since 2021.
She is a Member-President Business Leaders Cabinet at Rutgers State University of New Jersey since 2012 and a Trustee at Stonehill College, Inc.Former roles include Chief Executive Officer & Director at Avon Products, Inc. from 2012 to 2018.
Vice Chairman-Executive Committee at Johnson & Johnson in 2011.
Chairman-Worldwide Franchise at Ethicon, Inc. from 2005 to 2008.
Co-Chairman at US Foundation for Inspiration & Recognition of Science & Tech.
Chairman at Pharmaceuticals Group, LLC from 2009 to 2011.
Chairman at Surgical Care Group from 2008 to 2009.
Chairman at Certara, Inc. from 2018 to 2021.
Independent Non-Executive Director at NovoCure Ltd. from 2018 to 2022.
Director at The Partnership for New York City, Inc., Certara USA, Inc., Avon Co., Laronde, Inc., and Global President-Baby & Wound Care Franchise at McNeil-PPC, Inc.Education includes an MBA from Rutgers State University of New Jersey, graduate studies at Princeton University, and undergraduate studies at the University of Massachusetts Dartmouth.